Literature DB >> 33025344

Gastric Dieulafoy's lesion with subepithelial lesion-like morphology.

Takanao Tanaka1, Takeshi Sugaya2, Keiichi Tominaga2, Mimari Kanazawa2, Tsunehiro Suzuki2, Mutsumi Ishikawa2, Akira Yamamiya2, Takahiro Arisaka2, Yuichi Majima2, Makoto Iijima2, Kenichi Goda2, Atsushi Irisawa2.   

Abstract

Most cases of Dieulafoy's lesion, a rare cause of upper gastrointestinal bleeding, occur in the upper gastric corpus, usually with no edematous bulging or fold convergence around the mucosal defect. This report describes a case of Dieulafoy's lesion with subepithelial lesion (SEL)-like morphology. Endoscopic treatment by hemoclipping was difficult. Because of repeated bleeding, abdominal dynamic contrast computed tomography (CT) was conducted. Results showed a large caliber, tortuous artery branching directly from the celiac artery and feeding into the gastric wall of the gastric fundus. Rupture of this vessel in the submucosa was thought to be responsible for the SEL-like morphology. All findings indicated endoscopic treatment from the gastric mucosal side was too difficult. Therefore, we treated the lesion using interventional radiology (IR) technique of vascular embolization. If an SEL-like Dieulafoy's lesion cannot be treated by endoscopic hemostasis, then IR might be necessary to treat the vascular anomaly.

Entities:  

Keywords:  Caliber persistent artery; Coil embolization; Dieulafoy’s lesion; Subepithelial lesion

Mesh:

Year:  2020        PMID: 33025344     DOI: 10.1007/s12328-020-01257-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  2 in total

1.  The pathogenesis of Dieulafoy's gastric erosion.

Authors:  G L Juler; H G Labitzke; R Lamb; R Allen
Journal:  Am J Gastroenterol       Date:  1984-03       Impact factor: 10.864

2.  Lethal gastric hemorrhage from a caliber-persistent artery of the antrum - a branch of the right gastric artery.

Authors:  S Gurzu; C Copotoiu; C Molnar; L Azamfirei; I Jung
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.